Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
April 17, 2024 08:00 ET
|
Longeveron
Longeveron raises gross proceeds of ~$6.2 M from exercise of certain existing warrants to purchase an aggregate of 2,399,744 shares of its common stock.
Longeveron Announces Closing of $5.2 Million Public Offering
April 11, 2024 17:17 ET
|
Longeveron
Longeveron announces closing of previously announced public offering, raising $5.25 million in gross proceeds.
3D Cell Culture Report 2024: 3D Bioprinting Holds Potential to Revolutionize Organ Transplantation Space
April 08, 2024 08:53 ET
|
Research and Markets
Dublin, April 08, 2024 (GLOBE NEWSWIRE) -- The "3D Cell Culture - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for 3D Cell Culture...
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
April 08, 2024 08:30 ET
|
Longeveron
CEO Letter to Shareholders. Update on overall strategy, business objectives, approach to capital allocation, and 2024 key priorities and goals.
Life Science Tools Global Strategic Research Report 2024: Market to Reach $258.6 Billion by 2030 - Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
April 05, 2024 09:19 ET
|
Research and Markets
Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Life Science Tools - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Life Science Tools Market to...
Global Regenerative Medicine Industry Research 2023-2028: Market Driven by Wide Scope in New Therapeutic Areas and Collaborations and Partnerships
April 03, 2024 09:43 ET
|
Research and Markets
Dublin, April 03, 2024 (GLOBE NEWSWIRE) -- The "Global Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application...
BellaSeno Appoints Dr. Thomas Lingner as Chief Technology Officer and Inga Freyert as VP Quality and Regulatory Affairs
April 03, 2024 04:00 ET
|
AKAMPION
Further expansion of management expertise to accelerate BellaSeno´s market entry Leipzig, Germany, April 3, 2024 – BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable...
North America Leads the Way in Recombinant Cell Culture Supplements Market with Projected Robust Growth through 2028
April 02, 2024 12:54 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "North America Recombinant Cell Culture Supplements Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ...
Mesenchymal Stem Cells (MSCs) Advancements & Global Market Potential Highlighted in Comprehensive Strategic Report
April 01, 2024 04:06 ET
|
Research and Markets
Dublin, April 01, 2024 (GLOBE NEWSWIRE) -- The "Mesenchymal Stem Cells / Medicinal Signaling Cells (MSCs) - Advances & Applications, 2023" report has been added to ResearchAndMarkets.com's...
Global GMP Cell Therapy Consumables Market Projected to Reach $18.25 Billion in 2024, with Continued Growth through 2028
March 28, 2024 18:11 ET
|
Research and Markets
Dublin, March 28, 2024 (GLOBE NEWSWIRE) -- The "GMP Cell Therapy Consumables Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Market Growth DriversThe latest...